Clinical trial
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic…
NCT00002499 · Grupo Argentino de Tratamiento de la Leucemia Aguda, Other · Unknown status
Key facts
| NCT number | NCT00002499 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia |
| Official title | TREATMENT OF ALL IN FIRST BONE MARROW RELAPSE AFTER BFM PROTOCOLS |
| Lead sponsor | Grupo Argentino de Tratamiento de la Leucemia Aguda, Other |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug, Radiation |
| Interventions | asparaginase, cytarabine, daunorubicin hydrochloride, dexamethasone, methotrexate, prednisone, vincristine sulfate, radiation therapy |
| Start date | Jan 1, 1990 |
| First posted | Aug 23, 2004 |
| Last update posted | Sep 20, 2013 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: